| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 04/28/2010 | EP2178871A2 Cyclic ethers |
| 04/28/2010 | EP2178562A1 Synergistic combinations of vr-1 antagonists and cox-2 inhibitors |
| 04/28/2010 | EP2178545A2 Fraction of melissa leaf extract having angiogenesis and mmp inhibitory activities, and composition comprising the same |
| 04/28/2010 | EP2178525A1 Resveratrol complex and process for the preperation |
| 04/28/2010 | EP2178371A1 Heterocyclic modulators of cannabinoid receptors |
| 04/28/2010 | EP1881967B1 Substituted benzo(d)isoxazol-3-yl amine compounds as analgesics |
| 04/28/2010 | EP1635859B1 Therapeutic use of pam |
| 04/28/2010 | EP1581532B1 Pyrazolo¬3,4-b pyridine compounds, and their use as phosphodiesterase inhibitors |
| 04/28/2010 | EP1420785B1 Substituted indeno [1,2-c]isoquinoline derivatives and methods of use thereof |
| 04/28/2010 | EP1363640B1 Nucleic acid derivatives |
| 04/28/2010 | CN1976937B The extract of bulbophgllum radiatum lindl and the preparation and the use |
| 04/28/2010 | CN1761686B Proteoglycan isolated from cartilaginous fish and process for producing the same |
| 04/28/2010 | CN1712049B Preparation of Duyiwei effervescent tablet |
| 04/28/2010 | CN1703199B Aggregate with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially throug |
| 04/28/2010 | CN1698686B 'Duyiwei' soft capsule and its preparation |
| 04/28/2010 | CN1678333B Composition comprising the extract of actinidia arguta and related species for the prevention and treatment of allergic disease and non-allergic inflammatory disease |
| 04/28/2010 | CN1658877B Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 04/28/2010 | CN1658855B O-substituted hydroxyaryl derivatives |
| 04/28/2010 | CN1652698B Method and dietary composition for improving lipid digestibility |
| 04/28/2010 | CN1652697B Method and dietary composition for improving fat digestibility |
| 04/28/2010 | CN1652696B Method of improving absorption of vitamin E by a pet animal |
| 04/28/2010 | CN1556808B Cosmetic comprising heterocyclic compound based on N6-substituted adenine, |
| 04/28/2010 | CN1555417B Paramyxovirus vector for gene transfer to the cardiovascular system |
| 04/28/2010 | CN1524517B Oral medicament composition containing non-steroid antiphlogistic drugs and its preparation method |
| 04/28/2010 | CN1496271B Method of treating diseases in association with decrease in expression of AOP-1 gene or AOP-1 and remedies for diseases |
| 04/28/2010 | CN1468307B Anti-dual integrin antibodies, compositions, methods and uses |
| 04/28/2010 | CN1416335B New self emulsifying drug delivery system |
| 04/28/2010 | CN101698093A Drug composition oral preparation used for relaxing tendons and activating collaterals and preparation method thereof |
| 04/28/2010 | CN101698089A Traditional Chinese medicine volatile oil clathrate compound and preparation method thereof |
| 04/28/2010 | CN101698074A Medicine for treating soft tissue pain and preparation method thereof |
| 04/28/2010 | CN101698072A Traditional Chinese medicine composite for treating rheumatic arthritis and preparation method thereof |
| 04/28/2010 | CN101698058A Medicine for treating chronic arthralgia and preparation method thereof |
| 04/28/2010 | CN101698055A Traditional Chinese medicine medicated wine |
| 04/28/2010 | CN101698038A Paster for treating cancer pain and preparation method thereof |
| 04/28/2010 | CN101698033A Big plaster for treating various rheumatic osteopathy and traumatic injuries |
| 04/28/2010 | CN101698005A Gold granules used for treating cold and influenza and preparation method thereof |
| 04/28/2010 | CN101697993A Application of Momordica cochinchinensis oil in preparing medicaments with anti-inflammatory effect |
| 04/28/2010 | CN101697959A Potassium sodium dehydroandrographolide succinate and sodium chloride injection and preparation method thereof |
| 04/28/2010 | CN101014560B Wikstroemia indeca extract, their production and use in the production of anti-inflammatory pharmaceutical |
| 04/27/2010 | USRE41287 Cyclic agonists and antagonists of C5A receptors and G Protein-coupled receptors |
| 04/27/2010 | USRE41278 useful to alleviate or improve various cosmetic conditions and dermatological disorders, including changes or damage to skin, nail and hair associated with intrinsic aging and/or extrinsic aging, as well as changes or damage caused by extrinsic factors |
| 04/27/2010 | US7705151 for treating inflammatory and allergic diseases; 2-methylnicotinic acid derivative is treated with a strong base such as lithium diisopropylamide (LDA) in a suitable solvent such as THF to form the dianion, followed by addition of a nitrile, to provide [1,6]-naphthyridin-5-ol, chlorinating with POCl3 |
| 04/27/2010 | US7705125 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders |
| 04/27/2010 | US7705124 Leucine-based motif and clostridial neurotoxins |
| 04/27/2010 | US7705050 Amides, useful in the inhibition of IL-8-induced chemotaxis of neutrophils |
| 04/27/2010 | US7705023 Indoles useful in the treatment of inflammation |
| 04/27/2010 | US7705015 Substituted pyrroline kinase inhibitors |
| 04/27/2010 | US7704960 Administering Erythromycin A having had the cladinose moiety in the 3-position removed by acidolysis to produce an antiinflammatory agent having no antibiotic properties; chronic respiratory system disorders; cytokine suppressive antiinflammatory drugs; antiarthritic agents; antiischemic agents |
| 04/27/2010 | US7704952 treating diabetes or obesity using isolated polypeptide is covalently modified with a water-soluble polymer |
| 04/27/2010 | US7704526 Sustained release composition for oral administration of drugs |
| 04/27/2010 | CA2563042C 4-2-(cycloalkylamino)pyrimidin-4-yl-(phenyl)-imidazolin-2-one derivatives as p38 map-kinase inhibitors for the treatment of inflammatory diseases |
| 04/27/2010 | CA2493667C Vanilloid receptor ligands and their use in treatments |
| 04/27/2010 | CA2435552C A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis |
| 04/27/2010 | CA2422378C Pyrazole compounds useful as protein kinase inhibitors |
| 04/27/2010 | CA2413857C Pd-l2 molecules: pd-1 ligands and uses therefor |
| 04/27/2010 | CA2354213C N-triazolylmethyl-piperazine compounds with neurokinin-receptor antagonist activity |
| 04/27/2010 | CA2338968C Glucocorticoid-selective agents |
| 04/27/2010 | CA2323776C Cytokine receptor common gamma chain like |
| 04/27/2010 | CA2321951C Dietary control of arachidonic acid metabolism |
| 04/27/2010 | CA2179909C Ligand that binds fas antigen |
| 04/22/2010 | WO2010045599A1 Pharmaceutical compositions with attenuated release of phenolic opioids |
| 04/22/2010 | WO2010045311A1 Methods of using nitrogen-containing heterocycle derivatives |
| 04/22/2010 | WO2010045197A1 Spiro-oxindole compounds and their use as therapeutic agents |
| 04/22/2010 | WO2010044681A1 A medicinal product and treatment |
| 04/22/2010 | WO2010043867A1 Pyrrolo [2, 3-d] pyrimidines as inhibitors of hsp90 |
| 04/22/2010 | WO2010043865A1 Inhibitors of hsp90 |
| 04/22/2010 | WO2010043412A1 Co-crystals of tramadol and nsaids |
| 04/22/2010 | WO2010043377A1 New 2-amidothiadiazole derivatives |
| 04/22/2010 | WO2010043045A1 Annexin and its use to treat inflammatory disorders |
| 04/22/2010 | WO2010043000A1 S1p receptors modulators and their use thereof |
| 04/22/2010 | WO2010011533A3 Compositions and methods for increasing serum antioxidant concentrations |
| 04/22/2010 | WO2010011325A3 Synthesis and utilization of small molecules for the treatment of inflammation associated with interleukin-1 signaling |
| 04/22/2010 | WO2010011296A3 Deacetylase inhibitors and uses thereof |
| 04/22/2010 | WO2010009116A3 Methods and compositions for treating postoperative pain comprising nonsteroidal anti-inflammatory agents |
| 04/22/2010 | WO2010009111A3 A drug depot implantable within a synovial joint |
| 04/22/2010 | WO2009129491A4 Beta adrenergic receptor agonists for treatment of pain and/or inflammation |
| 04/22/2010 | US20100099850 Human cytokine receptor |
| 04/22/2010 | US20100099767 Topical Pharmaceutical Formulation |
| 04/22/2010 | US20100099766 Topical NSAID compositions having sensate component |
| 04/22/2010 | US20100099756 Uses of incensole, incensole acetate and derivatives thereof |
| 04/22/2010 | US20100099729 Nitric oxide donor compounds |
| 04/22/2010 | US20100099722 2-(benzimidazol-1-yl)-n-(4-phenylthiazol-2-yl) acetamide derivatives |
| 04/22/2010 | US20100099714 AMPA and NMDA Receptor Antagonists for Neurodegenerative Diseases |
| 04/22/2010 | US20100099694 2-anilino-4-heteroaryl pyrimidine derivatives, and preparation thereof as medicaments, pharmaceutical compositions, and in particular ikk inhibitors |
| 04/22/2010 | US20100099693 New combination for use in the treatment of inflammatory disorders |
| 04/22/2010 | US20100099689 Methods of modulating ppar gamma-type receptors |
| 04/22/2010 | US20100099688 Novel phosphodiesterase inhibitors |
| 04/22/2010 | US20100099680 Pteridinone derivatives as p13-kinases inhibitors |
| 04/22/2010 | US20100099678 Dialkylamino alkyl esters of pivagabine as medicaments for the treatment of central nervous system disorders |
| 04/22/2010 | US20100099673 Decahydroquinoline analogs as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases |
| 04/22/2010 | US20100099659 Inhibitors of Bruton's Tyrosine Kinase |
| 04/22/2010 | US20100099654 Fatty acid esters of glucocorticoids as anti-inflammatory and anti-cancer agents |
| 04/22/2010 | US20100099650 Nasal spray composition and method for treating rhinitis, sinusitis or both |
| 04/22/2010 | US20100099617 Secreted proteins |
| 04/22/2010 | US20100099606 Effective use method of medicaments and method of preventing expression of side effect |
| 04/22/2010 | US20100099602 Pharmaceutical compositions and methods of use for the prevention and treatment of hypoxic injury |
| 04/22/2010 | US20100098715 Annexin ii compositions for treating or monitoring inflammation or immune-mediated disorders |
| 04/22/2010 | US20100098709 Antibodies Specific For The Complex Of Interleukin-6 And The Interleukin-6 Receptor |
| 04/22/2010 | US20100098689 4-1 bb ligand in inflammatory diseases |
| 04/22/2010 | US20100098686 Method for reducing levels of C-reactive protein |